Taken together, through in vitro and in vivo experiments, this study found that targeting the hsa_circRNA_103809/miR-377-3p/GOT1 pathway inhibited cell proliferation and viability, and triggered cell apoptosis to increase cisplatin-sensitivity in NSCLC cells. The gene discussed is GOT1; the disease is non-small cell lung carcinoma.